Acute monocytic leukemia
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Acute monocytic leukemia Classification and external resources | |
| ICD-10 | C93.0 |
|---|---|
| ICD-9 | 206.0 |
| MeSH | D007948 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-525-6884
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Acute monocytic leukemia (AMoL, or AML-M5) is considered a type of acute myeloid leukemia. In order to fulfill World Health Organization (WHO) criteria for AML-5, a patient must have greater than 20% blasts in the bone marrow, and of these, greater than 80% must be of the monocytic lineage. A further subclassification (M5a versus M5b) is made depending on whether the monocytic cells are predominantly monoblasts (>80%) (acute monoblastic leukemia) or a mixture of monoblasts and promonocytes (<80% blasts). Monoblasts can be distinguished by having a roughly circular nucleus, delicate lacy chromatin, and abundant, often basophilic cytoplasm. These cells may also have pseudopods. By contrast, promonocytes have a more convoluted nucleus, and their cytoplasm may contain metachromatic granules. Monoblasts are typically MPO negative and promonocytes are MPO variable. Both monoblasts and promonocytes stain positive for non-specific esterase (NSE), however NSE may often be negative.
Immunophenotypically, M5-AML variably express myeloid (CD13, CD33) and monocytic (CD11b, CD11c) markers. Cells may aberrantly express B cels marker CD20 and the NK marker CD56. Monoblasts may be positive for CD34.
M5 is associated with characteristic chromosomal abnormalities, often involving 11q23 or t(9;11)affecting the MLL locus, however the MLL translocation is also found in other AML subtypes. MLL is believed to be prognostically unfavorable in AML-M5 compared to other genetic alterations involving MLL such as t(9;11) The t(8;16) translocation in MLL is associated with hemophagocytosis.
AML-M5 is thought to be associated with exposure to epidophyllotoxins.
AML-M5 is treated with intensive chemotherapy (such as anthracyclines) or with bone marrow transplantation.
External links
WikiDoc Research Resources for Acute monocytic leukemia (Click show to right to view) | |
|---|---|
| Articles on Acute monocytic leukemia | Most recent articles on Acute monocytic leukemia • Most cited articles on Acute monocytic leukemia • Review articles on Acute monocytic leukemia • Articles on Acute monocytic leukemia in N Eng J Med, Lancet, BMJ |
| Media (Slides, Video, Images, MP3) on Acute monocytic leukemia | Powerpoint slides on Acute monocytic leukemia • Images of Acute monocytic leukemia • Photos of Acute monocytic leukemia • Podcasts & MP3s on Acute monocytic leukemia • Videos on Acute monocytic leukemia |
| Evidence Based Medicine Regarding Acute monocytic leukemia | Cochrane Collaboration on Acute monocytic leukemia • Bandolier on Acute monocytic leukemia • TRIP on Acute monocytic leukemia |
| Cost Effectiveness of Acute monocytic leukemia | Cost Effectiveness of Acute monocytic leukemia |
| Clinical Trials Involving Acute monocytic leukemia | Ongoing Trials on Acute monocytic leukemia at Clinical Trials.gov • Trial results on Acute monocytic leukemia • Clinical Trials on Acute monocytic leukemia at Google |
| Guidelines / Policies / Government Resources (FDA/CDC) Regarding Acute monocytic leukemia | US National Guidelines Clearinghouse on Acute monocytic leukemia • NICE Guidance on Acute monocytic leukemia • NHS PRODIGY Guidance • FDA on Acute monocytic leukemia • CDC on Acute monocytic leukemia |
| Textbook Information on Acute monocytic leukemia | Books and Textbook Information on Acute monocytic leukemia |
| Pharmacology Resources on Acute monocytic leukemia | Dosing of Acute monocytic leukemia • Drug interactions with Acute monocytic leukemia • Side effects of Acute monocytic leukemia • Allergic reactions to Acute monocytic leukemia • Overdose information on Acute monocytic leukemia • Carcinogenicity information on Acute monocytic leukemia • Acute monocytic leukemia in pregnancy • Pharmacokinetics of Acute monocytic leukemia • |
| Genetics, Pharmacogenomics, and Proteinomics of Acute monocytic leukemia | Genetics of Acute monocytic leukemia • Pharmacogenomics of Acute monocytic leukemia • Proteomics of Acute monocytic leukemia |
| Newstories on Acute monocytic leukemia | Acute monocytic leukemia in the news • Be alerted to news on Acute monocytic leukemia • News trends on Acute monocytic leukemia |
| Commentary on Acute monocytic leukemia | Blogs on Acute monocytic leukemia |
| Patient Resources on Acute monocytic leukemia | Patient resources on Acute monocytic leukemia • Discussion groups on Acute monocytic leukemia • Patient Handouts on Acute monocytic leukemia • Directions to Hospitals Treating Acute monocytic leukemia • Risk calculators and risk factors for Acute monocytic leukemia |
| Healthcare Provider Resources on Acute monocytic leukemia | Symptoms of Acute monocytic leukemia • Causes & Risk Factors for Acute monocytic leukemia • Diagnostic studies for Acute monocytic leukemia • Treatment of Acute monocytic leukemia |
| Continuing Medical Education (CME) Programs on Acute monocytic leukemia | CME Programs on Acute monocytic leukemia |
| International Resources on Acute monocytic leukemia | Acute monocytic leukemia en Espanol • Acute monocytic leukemia en Francais |
| Business Resources on Acute monocytic leukemia | Acute monocytic leukemia in the Marketplace • Patents on Acute monocytic leukemia |
| Informatics Resources on Acute monocytic leukemia | List of terms related to Acute monocytic leukemia |
| ||||
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

